Detalles de la búsqueda
1.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol;
185: 128-137, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38412736
2.
Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis.
Support Care Cancer;
32(5): 292, 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38632132
3.
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
Aust N Z J Obstet Gynaecol;
2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38299485
4.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Lancet Oncol;
24(5): 468-482, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080223
5.
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
Int J Gynecol Cancer;
33(8): 1208-1214, 2023 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380217
6.
Management of Malignant Bowel Obstruction: An Innovative Proactive Outpatient Nurse-Led Model of Care for Patients With Advanced Gynecologic Cancer.
J Nurs Care Qual;
38(1): 69-75, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36214674
7.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Gynecol Oncol;
166(2): 254-262, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35718565
8.
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients.
Int J Gynecol Cancer;
32(7): 906-912, 2022 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321889
9.
Interobserver and intraobserver variability of RECIST assessment in ovarian cancer.
Int J Gynecol Cancer;
32(5): 656-661, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379690
10.
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer.
Int J Gynecol Cancer;
32(4): 560-565, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551895
11.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer;
32(6): 761-768, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086926
12.
Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer.
Gynecol Oncol;
162(3): 720-727, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34454680
13.
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
Cancer;
126(10): 2139-2145, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32097505
14.
Supported self-management as a model for end-of-life care in the setting of malignant bowel obstruction: A qualitative study.
Gynecol Oncol;
157(3): 745-753, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32217004
15.
Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer.
Gynecol Oncol;
159(2): 539-545, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32912664
16.
Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply.
Lancet Oncol;
24(7): e290, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414018
17.
Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia.
Intern Med J;
47(8): 888-893, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28485058
18.
Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World Data.
Am Soc Clin Oncol Educ Book;
43: e390876, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285556
19.
Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice.
Patient Relat Outcome Meas;
14: 111-126, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188148
20.
Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma.
Asia Pac J Clin Oncol;
2023 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37566390